[{"Assets_0_Q3_USD":"4620840000.0","CIK":"875320","CommonStockSharesIssued_0_Q3_shares":"255610812.0","CommonStockSharesOutstanding_0_Q3_shares":"255610812.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.51","EarningsPerShareBasic_3_Q3_USD":"2.15","EarningsPerShareDiluted_1_Q3_USD":"0.5","EarningsPerShareDiluted_3_Q3_USD":"2.11","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","MinorityInterest_0_Q3_USD":"28365000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"955708000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"128732000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"546208000.0","NetIncomeLoss_1_Q3_USD":"128746000.0","NetIncomeLoss_3_Q3_USD":"546369000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","ProfitLoss_1_Q3_USD":"128456000.0","ProfitLoss_3_Q3_USD":"562007000.0","RevenuesConverted_1_Q3_USD":"784535000.0","RevenuesConverted_3_Q3_USD":"2177491000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"2934481000.0","StockholdersEquity_0_Q3_USD":"2906116000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"259788000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"258972000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"254905000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"254096000.0","filed":"20181025","footnote":null,"form":"10-Q","fp":"Q3","fy":"2018.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20180930","qtrs":"0","uom":"USD"}]